Insulin - Structure, function, design

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue SUPPL. 2, 1999, Pages

  Brandenburg, Dietrich ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Bioactivity; Improved insulin therapy; Insulin analogues; Nuclear magnetic resonance; Receptor; Structure function

Indexed keywords

EID: 0002418909     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212143     Document Type: Article

References (18)

1. Bao SJ, Xie DL, Zhang JP, Chang WR, Liang DC: Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 A resolution: implications for receptor binding. Proc Natl Acad Sci U S A 94:2975-2980, 1997
2. Brandenburg D: Des-PheB1-insulin, a crystalline analogue of bovine insulin. Hoppe Seylers Z Physiol Chem 350: 741-750, 1969
3. Brandenburg D: Structure-function relationships of insulin, in Frontiers in Insulin Pharmacology (eds M Berger, FA Gries) Georg Thieme Stuttgart pp 60-70, 1993
4. Brange J, Ribel U, Hansen JF, Dodson G, Hansen MT, Havelund S, Melberg SG, Norris F, Morris K, Snel L, Sorensen AR, Voigt HO: Monomeric insulins obtained by protein engineering and their medical implications. Nature 333: 679-682, 1988
5. Chance RE, Frank BH, Radzuik JM, DiMarchi RD: Discovery and development of insulin lyspro. Drugs of Today 34 (Suppl C): 1-9, 1998
6. Ciszak E, Beals JM, Frank BH, Baker JC, Carter ND, Smith GD: Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin. Structure 3: 615-622,1995
7. Derewenda U, Derewenda Z, Dodson EJ, Dodson GG, Bing X, Markussen J: X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. J Mol Biol 220: 425-433, 1991
8. Derewenda U, Derewenda Z, Dodson GG, Hubbard RE, Korber F: Molecular structure of insulin: the insulin monomer and its assembly. Br Med Bull 45: 4-18, 1989
9. Du X, Tang JG: Effects of deleting A19 tyrosine from insulin. Biochem Mol Biol Int: 507-513, 1998
10. Fabry M, Schaefer E, Ellis L, Kojro E, Fahrenholz F, Brandenburg D: Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem 267: 8950-8956, 1992
11. Garrett TP, McKern NM, Lou M, Frenkel MJ, Bentley JD, Lovrecz GO, Elleman TC, Cosgrove LJ, Ward CW: Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 394: 395-399, 1998
12. Hilgenfeld R, Dörschung M, Geisen K, Neubauer H, Obermeier R, Seipke G, Berchtold H: Controlling insulin bioavailability by crystal contact engineering. Diabetologia 35: A193, 1992
13. Hua QX, Hu SQ, Frank BH, Jia W, Chu YC, Wang SH, Burke GT, Katsoyannis PG, Weiss, MA: Mapping the functional surface of insulin by design:structure and function of a novel A-chain analogue. J Mol Biol 264: 390-403, 1996
14. Hua QX, Hu SQ, Jia W, Chu YC, Burke GT, Wang SH, Wang RY, Katsoyannis PG, Weiss, MA: Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures. J Mol Biol 277: 103-118, 1998
15. Jorgensen AM, Olsen HB, Balschmidt P, Led JJ: Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin. J Mol Biol 257: 684-699, 1996
16. Whittingham JL, Havelund S, Jonassen I: Crystal structure of a prolonged-acting insulin with albumin-binding properties. Biochemistry 36: 2826-2831, 1997
17. Wollmer A, Gilge G, Brandenburg D, Gattner H-G: An insulin with the native sequence but virtually no activity. Biochemistry Hoppe-Seyler 375: 219-222, 1994
18. 2NH) substitution of amide bonds in the C-terminal portion of the insulin B chain. In: Peptides: Chemistry, structure and biology (eds PTP Kaumaya, RS Hodges) Mayflower Scientific Ltd, pp 641-642, 1996